EMPEROR PRESERVED
July 6, 2024PARAGLIDE HF
July 6, 2024EMPEROR PRESERVED
July 6, 2024PARAGLIDE HF
July 6, 2024EMPEROR PRESERVED
July 6, 2024PARAGLIDE HF
July 6, 2024The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
Read Study